Prudential Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.5K Buy
+10,655
New +$20K ﹤0.01% 2389
2025
Q2
Sell
-31,931
Closed -$145K 2460
2025
Q1
$145K Buy
+31,931
New +$169K ﹤0.01% 2102
2022
Q1
Sell
-4,209
Closed -$223K 2640
2021
Q4
$223K Sell
4,209
-204
-5% -$9.3K ﹤0.01% 2508
2021
Q3
$244K Buy
4,413
+640
+17% +$34.9K ﹤0.01% 2408
2021
Q2
$210K Buy
+3,773
New +$201K ﹤0.01% 2440

Other funds holding HCAT

Prudential Financial's HCAT Position: Q1 2026 in Review

Prudential Financial opened a new position in Health Catalyst (HCAT) in Q1 2026: 10,655 shares worth $13.5K. The stake represents ﹤0.01% of the portfolio and ranks #2389 among its holdings. This is a return to the name: Prudential Financial previously reported a position in HCAT as recently as Q1 2025.

Prudential Financial first reported a position in HCAT in Q2 2021 and has held it in 5 quarters since. The position peaked at $244K in Q3 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Prudential Financial held 10,655 shares of Health Catalyst worth $13.5K as of Q1 2026.
  • Health Catalyst was a new Prudential Financial position in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2389 holding.
  • Prudential Financial first reported a position in Health Catalyst in Q2 2021 and has held it in 5 quarters since.
  • Prudential Financial's Health Catalyst position peaked at $244K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.